Go Pro

Legal & General Group Plc Buys New Position in Innospec Inc. $IOSP

Innospec logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Legal & General Group Plc initiated a position in Innospec during the second quarter, purchasing 58,841 shares valued at approximately $4.8 million. Institutional investors collectively own 96.64% of the company.
  • Innospec reported quarterly adjusted earnings of $1.27 per share, exceeding estimates of $1.05, while revenue rose 11.8% year over year to $491.4 million.
  • The stock traded at $93.12, near its 12-month high of $96.68. Analyst sentiment remains mixed, with a consensus “Hold” rating, although Seaport Research Partners set a $110 price target.
  • Five stocks we like better than Innospec.

Legal & General Group Plc purchased a new position in Innospec Inc. (NASDAQ:IOSP - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 58,841 shares of the specialty chemicals company's stock, valued at approximately $4,789,000. Legal & General Group Plc owned approximately 0.24% of Innospec at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in IOSP. Arrowstreet Capital Limited Partnership grew its position in Innospec by 196.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 18,497 shares of the specialty chemicals company's stock worth $1,351,000 after acquiring an additional 12,259 shares in the last quarter. BlackRock Inc. purchased a new stake in Innospec during the second quarter valued at about $356,596,000. First Wilshire Securities Management Inc. lifted its stake in Innospec by 47.2% during the first quarter. First Wilshire Securities Management Inc. now owns 148,072 shares of the specialty chemicals company's stock worth $10,812,000 after purchasing an additional 47,498 shares during the last quarter. Western Standard LLC boosted its holdings in shares of Innospec by 894.0% in the 4th quarter. Western Standard LLC now owns 268,367 shares of the specialty chemicals company's stock worth $20,541,000 after purchasing an additional 241,367 shares in the last quarter. Finally, Intech Investment Management LLC boosted its holdings in shares of Innospec by 139.4% in the 4th quarter. Intech Investment Management LLC now owns 51,556 shares of the specialty chemicals company's stock worth $3,946,000 after purchasing an additional 30,023 shares in the last quarter. Institutional investors own 96.64% of the company's stock.

Innospec Trading Down 0.7%

Shares of NASDAQ:IOSP opened at $93.12 on Friday. The stock's 50-day moving average price is $88.00 and its 200-day moving average price is $81.12. Innospec Inc. has a 12-month low of $65.51 and a 12-month high of $96.68. The stock has a market capitalization of $2.29 billion, a P/E ratio of 19.00, a price-to-earnings-growth ratio of 2.49 and a beta of 0.93.

Innospec (NASDAQ:IOSP - Get Free Report) last released its earnings results on Tuesday, August 4th. The specialty chemicals company reported $1.27 earnings per share for the quarter, beating analysts' consensus estimates of $1.05 by $0.22. Innospec had a return on equity of 9.22% and a net margin of 6.60%.The company had revenue of $491.40 million during the quarter, compared to analyst estimates of $457.25 million. During the same quarter in the previous year, the company posted $1.26 EPS. Innospec's revenue for the quarter was up 11.8% on a year-over-year basis. As a group, research analysts predict that Innospec Inc. will post 5.03 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on IOSP shares. Seaport Research Partners reissued a "buy" rating and set a $110.00 price objective on shares of Innospec in a report on Thursday, August 6th. Weiss Ratings raised Innospec from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, August 6th. Finally, Wall Street Zen raised shares of Innospec from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 8th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of "Hold".

Get Our Latest Report on IOSP

Innospec Profile

(Free Report)

Innospec Incorporated NASDAQ: IOSP is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.

Recommended Stories

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP - Free Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Innospec Right Now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines